| Bioactivity | A40926, the precursor of Dalbavancin, is a second-generation glycopeptide antibiotic. A40926 inhibits gram-positive bacteria, and is very active against Neisseria gonorrhoeae[1]. | |||||||||
| Name | A40926 | |||||||||
| CAS | 102961-72-8 | |||||||||
| Formula | C83H88Cl2N8O28 | |||||||||
| Molar Mass | 1716.53 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Goldstein BP, et al. A40926, a new glycopeptide antibiotic with anti-Neisseria activity.Antimicrob Agents Chemother. 1987 Dec;31(12):1961-6. |
A40926
CAS: 102961-72-8 F: C83H88Cl2N8O28 W: 1716.53
A40926, the precursor of Dalbavancin, is a second-generation glycopeptide antibiotic. A40926 inhibits gram-positive bact
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.